A new study published in Therapeutic Innovation & Regulatory Science provides crucial insights into the design and ...
FDA open to pooling data from ongoing Phase I/II studies of LX2006 with data from pivotal trial, and to earlier co-primary endpoint assessment, to support a Biologics License Application FDA approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results